Get An Expert On Board: An Interview With Independent Medical Strategist Kayla Thompson-Riviere
October 22, 2025
Navigating today’s health care system can be a nightmare, especially if you or a loved one is sick and uncertain as to how to proceed: How to get an appointment with an appropriate specialist? How to get a quick and accurate diagnosis? How to determine the best treatment options? How…
Favorable Places: Considerations For Choosing The Best Place to Retire
February 14, 2024
There’s no doubt that some of us have tamped down our wanderlust during our working years, only to have it come roaring back once our ties to the office are untethered. Whether we have an itch to travel or an aspiration to lead a different type of life, we may…
The Costs Of Care: Dementia Raises The Financial Burden Of Caregiving
October 26, 2023
Receiving a diagnosis of dementia, whether the cause is Alzheimer’s, Lewy Body, vascular, or some other type, can be a devastating piece of news to digest. Chances are the person diagnosed has experienced many telltale symptoms even before the diagnosis is made, and often, it’s only in hindsight that the…
Eyes Wide Open: How To Approach The Medicare Annual Enrollment Period
October 18, 2023
If you’re an agebuzz reader, then you or a loved one likely has health insurance through Medicare: either the Original Medicare (along with a Medigap Supplemental Policy) or a Medicare Advantage plan, which covers all that Original Medicare does but may also offer additional benefits (along with certain costs and…
Weight And Wonder: Are The New Weight Loss Drugs Right For You?
July 26, 2023
Have you jumped on the weight-loss medication bandwagon yet? Have you wondered whether there’s finally a way for you to shed those extra pounds that have been plaguing you for decades and return to your svelte days of yesteryear? Although we’ve previously told you that a bit of extra weight…
A Hope And A Prayer: Who Will Gain Access To The New FDA-Approved Alzheimer’s Treatment?
July 12, 2023
If you or a loved one suffers from mild cognitive impairment or have been diagnosed with early Alzheimer’s Disease, you’ve likely followed the news over the last few months about a new treatment awaiting FDA approval. Well, that FDA approval has arrived: Leqembi, a medication that targets the amyloid plaques…